154 related articles for article (PubMed ID: 6206957)
1. Reactivity patterns with HLA-A2 variants indicate lack of identity between determinants defined by monoclonal antibodies and cytotoxic-T-cell clones.
Russo C; Flomenberg N; Dupont B; Ferrone S
Cell Immunol; 1984 Oct; 88(1):228-32. PubMed ID: 6206957
[TBL] [Abstract][Full Text] [Related]
2. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells.
Russo C; Ng AK; Pellegrino MA; Ferrone S
Immunogenetics; 1983; 18(1):23-35. PubMed ID: 6190744
[TBL] [Abstract][Full Text] [Related]
3. Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1.
Tsujisaki M; Sakaguchi K; Igarashi M; Richiardi P; Perosa F; Ferrone S
Transplantation; 1988 Mar; 45(3):632-9. PubMed ID: 3162340
[TBL] [Abstract][Full Text] [Related]
4. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
[TBL] [Abstract][Full Text] [Related]
5. Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens.
Perosa F; Tsujisaki M; Ferrone S
J Immunol; 1987 Apr; 138(7):2202-7. PubMed ID: 2435792
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human class II antigens by cloned cytolytic T cell reagents: a study using HLA loss mutant lymphoblastoid cell lines and monoclonal antibodies detecting the HLA-DP product(s).
Ohta N; Anichini A; Reinsmoen NL; Strassmann G; Wernet P; Bach FH
Hum Immunol; 1985 May; 13(1):21-32. PubMed ID: 3872867
[TBL] [Abstract][Full Text] [Related]
7. In vitro-isolated human cytotoxic T-lymphocyte clones detect variations in serologically defined HLA antigens.
Spits H; Breuning M; Ivanyi P; Russo C; de Vries JE
Immunogenetics; 1982; 16(6):503-12. PubMed ID: 6190736
[TBL] [Abstract][Full Text] [Related]
8. The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity.
Bernhard EJ; Le AX; Yannelli JR; Holterman MJ; Hogan KT; Parham P; Engelhard VH
J Immunol; 1987 Dec; 139(11):3614-21. PubMed ID: 2445816
[TBL] [Abstract][Full Text] [Related]
9. Antibody-induced association between discrete regions of HLA class I and II antigens.
Russo C; Nepo A; Lanza E; Igarashi M; Ferrone S
J Immunol; 1987 May; 138(10):3152-8. PubMed ID: 2437183
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the repertoire of anti-HLA antibodies with anti-idiotypes to a murine anti-HLA-A2,A28 monoclonal antibody.
Russo C; Pellegrino MA; Ferrone S
Hum Immunol; 1984 May; 10(1):57-67. PubMed ID: 6609912
[TBL] [Abstract][Full Text] [Related]
11. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
12. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
[TBL] [Abstract][Full Text] [Related]
13. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
Gaston JS; Rickinson AB; Epstein MA
J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
[TBL] [Abstract][Full Text] [Related]
15. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). II. Blocking of anti-class I CTL clones by anti-DR MoAb.
Anichini A; Ress S; Strassmann G; Bach FH
Hum Immunol; 1985 Jun; 13(2):139-43. PubMed ID: 2409062
[TBL] [Abstract][Full Text] [Related]
17. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
[TBL] [Abstract][Full Text] [Related]
18. Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigens.
Flomenberg N; Naito K; Duffy E; Knowles RW; Evans RL; Dupont B
Eur J Immunol; 1983 Nov; 13(11):905-11. PubMed ID: 6196208
[TBL] [Abstract][Full Text] [Related]
19. A cloned cytotoxic T-lymphocyte (CTL) line recognizing a subtype of HLA B27.
Breuning MH; Spits H; de Vries JE; Iványi P
Hum Immunol; 1984 Apr; 9(4):231-42. PubMed ID: 6201469
[TBL] [Abstract][Full Text] [Related]
20. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule.
Salter RD; Clayberger C; Lomen CE; Krensky AM; Parham P
J Exp Med; 1987 Jul; 166(1):283-8. PubMed ID: 2439636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
